Country Profile

Greece

Greece is a growing market for Indian pharmaceuticals — $95.2M in FY 2025–26, with 5.2× growth over the past decade. Medicines accounts for 64% of shipments, with vaccines contributing $662K. The compound annual growth rate since FY2015 stands at 16.2%.

🇬🇷 $95.2M · 5.2× growth since FY2015 · 16.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$95.2M
Exports FY2025–26 DGCIS
5.2×
Growth FY2015→2026
16.2%
CAGR FY2015→2026
64%
Medicines Share
5
Product Categories Supplied
Greece is a growing market for Indian pharmaceuticals — $95.2M in FY 2025–26, with 5.2× growth over the past decade. Medicines accounts for 64% of shipments, with vaccines contributing $662K. The compound annual growth rate since FY2015 stands at 16.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $61.3M (64.4%) Medicine Ingredients $28.5M (29.9%) Surgical & Hospital Supplies $3.02M (3.2%) Traditional & Herbal $1.77M (1.9%) Vaccines $662K (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Greece in the RBI overseas direct investment dataset (2011–2026).